Cargando…

Social determinants of health as drivers of fungal disease

Disparities in social determinants of health (SDOH) play a significant role in causing health inequities globally. The physical environment, including housing and workplace environment, can increase the prevalence and spread of fungal infections. A number of professions are associated with increased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jenks, Jeffrey D., Prattes, Juergen, Wurster, Sebastian, Sprute, Rosanne, Seidel, Danila, Oliverio, Matteo, Egger, Matthias, Del Rio, Carlos, Sati, Hatim, Cornely, Oliver A., Thompson, George R., Kontoyiannis, Dimitrios P., Hoenigl, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694587/ http://dx.doi.org/10.1016/j.eclinm.2023.102325

Ejemplares similares

COVID-19-associated fungal infections
por: Hoenigl, Martin, et al.
Publicado: (2022)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
por: Sprute, Rosanne, et al.
Publicado: (2021)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Blood Aspergillus PCR: The Good, the Bad, and the Ugly
por: Egger, Matthias, et al.
Publicado: (2020)

Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study
por: Hoenigl, Martin, et al.
Publicado: (2021)

EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis
por: Sprute, Rosanne, et al.
Publicado: (2022)

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
por: Prattes, Juergen, et al.
Publicado: (2016)

All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
por: Sprute, Rosanne, et al.
Publicado: (2021)

Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis
por: Egger, Matthias, et al.
Publicado: (2022)

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
por: Grothe, Jan, et al.
Publicado: (2022)

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

Race and ethnicity: Risk factors for fungal infections?
por: Jenks, Jeffrey D., et al.
Publicado: (2023)

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
por: Hoenigl, Martin, et al.
Publicado: (2023)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
por: Sprute, Rosanne, et al.
Publicado: (2022)

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
por: Sprute, Rosanne, et al.
Publicado: (2021)

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections
por: Sprute, Rosanne, et al.
Publicado: (2022)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico
por: Hoenigl, Martin, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Protocol for fungal infection following the induction of epithelial cell loss in larval zebrafish
por: Wurster, Sebastian, et al.
Publicado: (2021)

974. PD-1 Immune Checkpoint Blockade Improves Survival and Promotes Fungal Clearance in an Immunosuppressed Murine Invasive Pulmonary Aspergillosis (IPA) Model
por: Wurster, Sebastian, et al.
Publicado: (2019)

Editorial: Diagnostic Approaches for Aspergillus Infections
por: Salzer, Helmut J. F., et al.
Publicado: (2019)

Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
por: Seidel, Danila, et al.
Publicado: (2021)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

617. Laboratory capacities to diagnose and treat Invasive Fungal Infections in Europe: results from an ECMM survey
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

Das Geschlecht in der Infektiologie – wie Geschlechtsunterschiede die Immunantwort auf Infektionen beeinflussen
por: Horn, Carola, et al.
Publicado: (2023)

Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module
por: Wurster, Sebastian, et al.
Publicado: (2019)

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
por: Prattes, Juergen, et al.
Publicado: (2021)

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(®) registry and literature reports
por: Sprute, Rosanne, et al.
Publicado: (2020)

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

871. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Thompson, George R, et al.
Publicado: (2022)

Impact of ITS-Based Sequencing on Antifungal Treatment of Patients with Suspected Invasive Fungal Infections
por: Guenter, Sara, et al.
Publicado: (2020)

Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model
por: Wurster, Sebastian, et al.
Publicado: (2022)

Insect Bite–Associated Invasive Fungal Infections
por: Kontoyiannis, Panayiotis D, et al.
Publicado: (2019)

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Stemler, Jannik, et al.
Publicado: (2023)

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
por: Thompson III, George R, et al.
Publicado: (2020)

SuPAR levels in BAL fluid from patients with acute respiratory distress syndrome—a pilot study
por: Reisinger, Alexander C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_atjlqt8cs41q2cmc1ucrhh079g